Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Syncona Share Price
  4. Syncona Share Regulatory News
  5. Net Asset Value(s)

Pin to quick picksSyncona Regulatory News (SYNC)

Syncona Information

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
98.20    -0.80 (-0.81%)
Bid:
98.20
Ask:
99.00
Spread: 0.80 (0.815%)
Market Cap: £597.25m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Net Asset Value(s)

23 Nov 2016 09:29

BACIT Limited - Net Asset Value(s)

BACIT Limited - Net Asset Value(s)

PR Newswire

London, November 23

BACIT Limited(a closed-ended investment company incorporated in Guernsey with registration number 55514)

FUND NAMESEDOLNAV as at 31 October 2016Total Return MTDTotal Return from Inception (31/10/12)
BACIT LimitedB8P59C0129.40p+2.79%+39.58%

Date: 23rd November 2016

Enquiries:Northern Trust International Fund Administration Services (Guernsey) LimitedHarry Rouillard 44 (0)1481 745315

91011121314151617
Date   Source Headline
5th May 202212:05 pmRNSAutolus Reports Q1 2022 Financial Results
28th Apr 20227:00 amRNSSyncona invests in £75.5 million OMass Series B
11th Apr 20227:00 amRNSAnaveon announces initial clinical data
4th Apr 202212:34 pmRNSDirector/PDMR Shareholding
1st Apr 20227:00 amRNSFreeline reports Full Year 2021 Financial Results
24th Mar 20224:11 pmRNSHolding(s) in Company
23rd Mar 20228:30 amRNSFreeline enters into ADS purchase agreement
11th Mar 20227:00 amRNSFreeline registered direct offering
10th Mar 202212:05 pmRNSAutolus Reports Full Year 2021 Financial Results
9th Mar 20224:39 pmRNSDirector/PDMR Shareholding
9th Mar 20223:09 pmRNSHolding(s) in Company
7th Mar 20225:29 pmRNSDirector/PDMR Shareholding
1st Mar 202212:56 pmRNSAchilles reports Full Year 2021 Results
18th Feb 20227:00 amRNSCompletion of sale of Gyroscope Therapeutics
8th Feb 202212:05 pmRNSFreeline presents data in Fabry disease
31st Dec 20217:00 amRNSDirectorate Change
22nd Dec 20217:00 amRNSGyroscope to be acquired for up to $1.5 billion
16th Dec 20217:00 amRNSSyncona cornerstones Anaveon Series B
14th Dec 20217:00 amRNSFreeline reports 2022 priorities and guidance
13th Dec 20212:05 pmRNSFreeline presents data in haemophilia B
13th Dec 202112:05 pmRNSAutolus presents positive AUTO1 (obe-cel) data
29th Nov 20217:00 amRNSSyncona co-leads Series B financing in Quell
22nd Nov 20217:00 amRNSSyncona appoints new Directors
12th Nov 20211:56 pmRNSAchilles Presents Data at the SITC Annual Meeting
11th Nov 20217:00 amRNSHalf-year Report
10th Nov 20217:00 amRNSFreeline reports new data and 3rd Quarter Results
9th Nov 20211:31 pmRNSAchilles reports Third Quarter Financial Results
8th Nov 20211:05 pmRNSGyroscope Announces Sanofi Equity Investment
8th Nov 20217:00 amRNSBlackstone Life Science to invest $250m in Autolus
3rd Nov 202111:07 amRNSSyncona leads $87 million financing of Clade
3rd Nov 202111:05 amRNSAutolus reports Q3 2021 Financial Results
26th Oct 20217:00 amRNSNotice of Results
30th Sep 20213:59 pmRNSGyroscope announces additional positive data
17th Aug 20217:00 amRNSFirst Quarter Update
16th Aug 202112:07 pmRNSFreeline Reports Executive Change and Q2 Results
10th Aug 202112:05 pmRNSAchilles reports Second Quarter 2021 Results
5th Aug 202112:05 pmRNSAutolus reports Q2 2021 Financial Results
3rd Aug 20211:16 pmRNSResult of AGM - Replacement
3rd Aug 202112:32 pmRNSResult of AGM
30th Jul 202112:17 pmRNSTotal Voting Rights
27th Jul 20212:41 pmRNSHolding(s) in Company
15th Jul 202112:57 pmRNSIssue of shares pursuant to incentive scheme
1st Jul 202111:54 amRNSPublication of 2021 Annual Report & Notice of AGM
24th Jun 20217:00 amRNSAnaveon doses first patient in Phase I/II study
17th Jun 20217:00 amRNSFinal Results
17th Jun 20217:00 amRNSSyncona announces expansion of leadership team
11th Jun 202112:05 pmRNSAutolus to present additional data in AUTO1
18th May 20217:00 amRNSNotice of Results
18th May 20217:00 amRNSFreeline reports Q1 results
12th May 20213:05 pmRNSAutolus to present additional data in AUTO1
91011121314151617

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
LAND
Land Securities
LSE
-0.32%
JAM
JPMorgan American
LSE
-0.33%
PBEE
Pensionbee
LSE
1.47%
EME
Empyrean
LSE
0.00%
JPEI
JPEI.L
LSE
0.00%
Trending
MPL
Mercantile Ports & Logistics
LSE
23.08%
PREM
Premier African Minerals
LSE
-1.09%
FORG
Forgent
LSE
-7.89%
HEX
Helix Exploration
LSE
-0.67%
AVCT
Avacta Group
LSE
-2.10%